Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.560
-0.010 (-0.64%)
Dec 20, 2024, 4:00 PM EST - Market closed
Gain Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 41 | 49 | 37 | 65 | - | - | |
| Market Cap Growth | 9.12% | 32.75% | -42.34% | - | - | - | |
| Enterprise Value | 30 | 38 | 13 | 25 | - | - | |
| Last Close Price | 1.56 | 3.27 | 3.13 | 5.43 | - | - | |
| PS Ratio | - | 894.85 | 280.42 | 481.65 | - | - | |
| PB Ratio | 4.55 | 3.93 | 1.97 | 1.85 | - | - | |
| P/TBV Ratio | 5.19 | 3.99 | 1.99 | 1.86 | - | - | |
| EV/Sales Ratio | - | 691.99 | 96.63 | 186.53 | - | - | |
| Debt / Equity Ratio | 0.09 | 0.08 | 0.07 | 0.05 | 0.20 | -0.45 | |
| Asset Turnover | - | 0.00 | 0.00 | 0.01 | - | - | |
| Quick Ratio | 2.70 | 3.44 | 4.93 | 14.53 | 3.57 | 0.40 | |
| Current Ratio | 2.99 | 3.59 | 5.11 | 14.78 | 4.25 | 0.49 | |
| Return on Equity (ROE) | -263.14% | -141.57% | -65.52% | -67.73% | -124.39% | - | |
| Return on Assets (ROA) | -94.13% | -65.14% | -35.24% | -35.60% | -42.37% | -178.35% | |
| Return on Capital (ROIC) | -148.44% | -82.41% | -39.30% | -39.41% | -60.29% | -2487.10% | |
| Earnings Yield | -51.64% | -45.10% | -47.29% | -21.53% | - | - | |
| FCF Yield | -50.99% | -38.24% | -39.82% | -19.32% | - | - | |
| Buyback Yield / Dilution | -61.20% | -9.49% | -16.90% | -279.11% | -19.17% | - | |
| Total Shareholder Return | -61.20% | -9.49% | -16.90% | -279.11% | -19.17% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.